Dr. Irina Kostova Dimitrova, MD

Dr. Dimitrova practices at Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System.

Dr. Dimitrova's NPI, 1003847237, was assigned on July 5, 2006. Dr. Dimitrova holds Pennsylvania license MD479477.

Dr. Dimitrova's primary practice is Mount Sinai Hospital, at 15th Street at California, Chicago, IL 60608 in Cook County. The practice phone is (773) 542-2000. Dr. Dimitrova also practices at Mount Sinai Hospital Medical Center, 1500 S Fairfield Ave, Chicago, IL 60608.

Dr. Dimitrova's primary practice is Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System. Dr. Dimitrova is also affiliated with Ascension Columbia St. Mary's Hospital - Milwaukee Campus. The medical group on file is Ascension Medical Group. Dmand AI also links Dr. Dimitrova to 1 more hospital, 8 medical groups, 4 group practices and clinics and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimitrova practices, 8 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Dimitrova's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Dimitrova's licenses on file in 6 states: Pennsylvania, Colorado, Indiana, Michigan, Oregon and Washington.

CMS data shows 14 Medicare services from Dr. Dimitrova across 1 procedure code in 2024, for 37 Medicare patients. Medicare paid $238 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Dimitrova in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dimitrova's median patient age at 63, with 91% women.

In 2024, Dr. Dimitrova wrote 58 Medicare Part D claims for 21 patients. 98% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $34 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Dimitrova accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Dimitrova, published from 2012 to 2023. 2021 was the busiest year, with 3. Dr. Dimitrova's most frequent co-authors are Mohamed A. Elshaikh, MD, Kevin V. Albuquerque, MD and Sushil Beriwal, MD.

Dmand AI links Dr. Dimitrova to 1 clinical trial. Conditions studied include Carcinoma, Ovarian Epithelial and Ovarian Neoplasms.

CMS Open Payments shows 61 general payments to Dr. Dimitrova from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 42% of the total. TESARO, Inc. paid the most, $2,368.